US Patent Issued to Carmot Therapeutics on Nov. 4 for "GPCR receptor agonists, pharmaceutical compositions comprising the same, and methods for their use" (California Inventor)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,929, issued on Nov. 4, was assigned to Carmot Therapeutics Inc. (South San Francisco, Calif.).

"GPCR receptor agonists, pharmaceutical compositions comprising the same, and methods for their use" was invented by Xiaohui Du (Belmont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are GLP-1 receptor modulator compounds, pharmaceutical compositions, methods of their preparation, and methods of their use in treatment, and/or diagnosis."

The patent was filed on Jan. 14, 2025, under Application No. 19/020,628.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect...